Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)
Clinical trial NCT01986881 · COMPLETED
Trial details
- NCT number
- NCT01986881
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-04
- Primary completion
- 2019-12-27
- Enrollment
- 8246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.